Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3707132016 | Product containing tildrakizumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3707133014 | Tildrakizumab-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1201311000172114 | produit contenant du tildrakizumab | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1180211000172110 | product dat tildrakizumab bevat | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing tildrakizumab (medicinal product) | Has active ingredient | Tildrakizumab (substance) | true | Inferred relationship | Some | 1 | |
| Product containing tildrakizumab (medicinal product) | Is a | Product containing monoclonal antibody (product) | true | Inferred relationship | Some | ||
| Product containing tildrakizumab (medicinal product) | Is a | Interleukin 23 receptor antagonist-containing product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing tildrakizumab in parenteral dose form (medicinal product form) | Is a | True | Product containing tildrakizumab (medicinal product) | Inferred relationship | Some | |
| Product containing only tildrakizumab (medicinal product) | Is a | True | Product containing tildrakizumab (medicinal product) | Inferred relationship | Some |
Reference Sets
FHIR